Literature DB >> 7418254

Clinical, hematological and genetic features of sickle-cell anemia and sickle cell-beta thalassemia in a Brazilian population.

M A Zago, F F Costa, T C Freitas, C Bottura.   

Abstract

Clinical, hematological and genetic studies were carried out on 40 patients with symptomatic sickle-cell disease, selected on the basis of a predominant HbS fraction and absence of other abnormal hemoglobin variants. Family studies showed they included 26 homozygotes for the sickle-cell gene (SS) and 14 double heterozygotes for both the sickle-cell and the (0)beta-thalassemia genes ((S)(0)beta-thalassemia). Comparison of the two groups revealed the more common occurrence of splenomegaly, lower MCV and mCH, and higher HbA2 in (S)(0)beta-thalassemia. Total hemoglobin was slightly lower in SS disease but the difference was not significant. Fetal hemoglobin (HbF) was moderately elevated to similar levels in both groups. These results suggest a high incidence of S beta (0)-thalassemia in certain Brazilian mixed populations and confirm the severity of the double heterozygous state. The distinction between the two disorders is often difficult, but can be made on the basis of the hematological data taken together with family studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418254     DOI: 10.1111/j.1399-0004.1980.tb01366.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy.

Authors:  E A Donadi; R P Falcão
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

2.  Thalassaemia intermedia in a family with beta 0-thalassaemia and Hb Hasharon.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

3.  Bone marrow and peripheral blood globin chain synthesis in sickle cell beta zero thalassaemia.

Authors:  F F Costa; M A Zago
Journal:  J Med Genet       Date:  1986-06       Impact factor: 6.318

4.  The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.

Authors:  Sari Peretz; Leonid Livshits; Etheresia Pretorius; Asya Makhro; Anna Bogdanova; Max Gassmann; Ariel Koren; Carina Levin
Journal:  Front Physiol       Date:  2022-08-29       Impact factor: 4.755

5.  Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment.

Authors:  Fabia Neves; Osvaldo Alves Menezes Neto; Larissa Bueno Polis; Sarah Cristina Bassi; Denise Menezes Brunetta; Ana Cristina Silva-Pinto; Ivan Lucena Angulo
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.